C4 Therapeutics (CCCC) Share-based Compensation (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.34% |
| Dec 31, 2025 | -12.76% |
| Sep 30, 2025 | -7.99% |
| Jun 30, 2025 | -9.35% |
| Mar 31, 2025 | -33.13% |
| Dec 31, 2024 | -6.75% |
| Sep 30, 2024 | 38.40% |
| Jun 30, 2024 | 2.67% |
| Mar 31, 2024 | -2.26% |
| Dec 31, 2023 | -22.45% |
| Sep 30, 2023 | 27.63% |
| Jun 30, 2023 | 2.78% |
| Mar 31, 2023 | -9.65% |
| Dec 31, 2022 | 15.11% |
| Sep 30, 2022 | -26.23% |
| Jun 30, 2022 | -8.84% |
| Mar 31, 2022 | 40.69% |
| Dec 31, 2021 | 4.39% |
| Sep 30, 2021 | 16.41% |
| Jun 30, 2021 | 35.97% |
| Mar 31, 2021 | 41.41% |
| Dec 31, 2020 | 523.62% |
| Sep 30, 2020 | 170.81% |
| Jun 30, 2020 | 38.79% |
| Mar 31, 2020 | -84.09% |
| Dec 31, 2019 | 16.27% |